Loading provider…
Loading provider…
Internal Medicine Physician in Northridge, CA
NPI: 1033174826Primary Practice Location
Masoud M Azizad MD Inc
18433 W Roscoe Blvd, Northridge, CA
Primary Employer
Masoud M Azizad MD Inc
n2uaesthetics.com
HQ Phone
Get MD Masoud's Phone NumberMobile
Get MD Masoud's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2001 - 2027

American Board of Internal Medicine
Internal Medicine
Santa Barbara Cottage Hospital
Residency • Internal Medicine
1999 - 2002
New York Medical College
nymc.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 264 | 1,008 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 196 | 414 |
| 3 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 145 | 156 |
| 4 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 129 | 129 |
| 5 | 93922Ultrasound study of arteries of both arms and legs | 127 | 133 |
Authors: Rafael Canadas-Zizzias, Rajiv Agarwal, George Fadda, German Hernandez, Bertram Pitt, Rajiv Agarwal
Journal: Am J Nephrol
Publication Date: 2019-10-25
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Authors: Barry Heller, Robert Gottlieb, Ramesh Nathan, Awawu Igbinadolor, Ajay Nirula, Chad Crystal, Gregory Huhn, Valentina Stosor, Jose Cardona
Journal: N Engl J Med
Publication Date: 2021-07-14
Authors: Cameron Wolfe, Robert Coombs, Elizabeth Duke, Wayne Holman, Joseph Eron
Journal: Sci Transl Med
Publication Date: 2022-01-19
Lead Sponsor: Arrowhead Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: ARO-APOC3
Lead Sponsor: Ridgeback Biotherapeutics, LP
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: Placebo (PBO), DRUG: Molnupiravir 200 mg, DRUG: Molnupiravir 400 mg, DRUG: Molnupiravir 800 mg
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Iron therapy, DRUG: Daprodustat (GSK1278863)